Target: ₹1,820

CMP: ₹1,597.90

Inventurus Knowledge Solutions Ltd (IKS) announced a $17 million investment via its US subsidiary to acquire a 48.02 per cent stake in IKS WWMG MSO LLC, a newly formed Management Services Organisation (MSO) in the US.

We reckon a resemblance with the Palomar-like deal blueprint (announced in Q3FY25, wherein IKS paid $16.5 million). This joint venture investment reflects IKS’ maturing capital strategy—moving from balance-sheet leveraged deals to structured, transparent, and accountable JVs. It will likely forge client stickiness for IKS. Success shall hinge on disciplined execution, integration with core offerings, and realisation of strategic and financial synergies.

IKS has come up with three key client engagement models: Underwriting performance outcome model (e.g., Palomar Health – running successfully currently). Investing in medical group growth. JV structure, which has the lowest level of capital requirement – currently in use for WWMG deal. These constructs lead to higher EBITDA gains on top of ~900bps of EBITDA gain just from platform implementation – from synergies (220 bps) and compounding effect (60 bps), resulting in total EBITDA gains worth 1,170 bps.

We maintain our Add rating on IKS with a Q2FY27 TP of ₹1,820 (based on 35x target P/E).

Key risk: Lack of cost and revenue synergies with Aquity.

Published on July 4, 2025